| Phenotype and genotype of pancreatic cancer cell lines EL Deer, J González-Hernández, JD Coursen, JE Shea, J Ngatia, ... Pancreas 39 (4), 425-435, 2010 | 1069 | 2010 |
| Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression A Fukuda, SC Wang, JP Morris, AE Folias, A Liou, GE Kim, S Akira, ... Cancer cell 19 (4), 441-455, 2011 | 561 | 2011 |
| The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates K E Poruk, D Z Gay, K Brown, J D Mulvihill, K M Boucher, C L Scaife, ... Current molecular medicine 13 (3), 340-351, 2013 | 433 | 2013 |
| Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF DB Pike, S Cai, KR Pomraning, MA Firpo, RJ Fisher, XZ Shu, ... Biomaterials 27 (30), 5242-5251, 2006 | 401 | 2006 |
| Early detection of sporadic pancreatic cancer: summative review ST Chari, K Kelly, MA Hollingsworth, SP Thayer, DA Ahlquist, ... Pancreas 44 (5), 693-712, 2015 | 309 | 2015 |
| Screening for pancreatic cancer: why, how, and who? KE Poruk, MA Firpo, DG Adler, SJ Mulvihill Annals of surgery 257 (1), 17-26, 2013 | 309 | 2013 |
| Inverse association between adiposity and telomere length: The Fels Longitudinal Study M Lee, H Martin, MA Firpo, EW Demerath American Journal of Human Biology 23 (1), 100-106, 2011 | 244 | 2011 |
| Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants RA Peattie, AP Nayate, MA Firpo, J Shelby, RJ Fisher, GD Prestwich Biomaterials 25 (14), 2789-2798, 2004 | 229 | 2004 |
| Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training SS Gounder, S Kannan, D Devadoss, CJ Miller, KS Whitehead, ... Public Library of Science 7 (9), e45697, 2012 | 202 | 2012 |
| The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma G Von Figura, A Fukuda, N Roy, ME Liku, JP Morris Iv, GE Kim, HA Russ, ... Nature cell biology 16 (3), 255-267, 2014 | 193 | 2014 |
| Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle CJ Miller, SS Gounder, S Kannan, K Goutam, VR Muthusamy, MA Firpo, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (6 …, 2012 | 152 | 2012 |
| Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels CM Riley, PW Fuegy, MA Firpo, XZ Shu, GD Prestwich, RA Peattie Biomaterials 27 (35), 5935-5943, 2006 | 143 | 2006 |
| Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity M Capello, JV Vykoukal, H Katayama, LE Bantis, H Wang, DL Kundnani, ... Nature communications 10 (1), 254, 2019 | 141 | 2019 |
| Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation … NS Rajasekaran, S Varadharaj, GD Khanderao, CJ Davidson, S Kannan, ... Antioxidants & redox signaling 14 (6), 957-971, 2011 | 136 | 2011 |
| Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer M Capello, LE Bantis, G Scelo, Y Zhao, P Li, DS Dhillon, NJ Patel, ... JNCI: Journal of the National Cancer Institute 109 (4), djw266, 2017 | 132 | 2017 |
| Toward development of a surface-enhanced Raman scattering (SERS)-based cancer diagnostic immunoassay panel JH Granger, MC Granger, MA Firpo, SJ Mulvihill, MD Porter Analyst 138 (2), 410-416, 2013 | 119 | 2013 |
| Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma KE Poruk, MA Firpo, CL Scaife, DG Adler, LL Emerson, KM Boucher, ... Pancreas 42 (2), 193-197, 2013 | 118 | 2013 |
| Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels R Elia, PW Fuegy, A VanDelden, MA Firpo, GD Prestwich, RA Peattie Biomaterials 31 (17), 4630-4638, 2010 | 96 | 2010 |
| Biomarkers in pancreatic adenocarcinoma: current perspectives DS Swords, MA Firpo, CL Scaife, SJ Mulvihill OncoTargets and therapy, 7459-7467, 2016 | 92 | 2016 |
| BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages A Rosati, A Basile, R D’Auria, M d’Avenia, M De Marco, A Falco, M Festa, ... Nature communications 6 (1), 8695, 2015 | 88 | 2015 |
